TMX Newsfile

IN THE PRESS

Adaptimmune and GSK Have Agreed Terms for Transfer of PRAME and NY-ESO Target Programs back to Adaptimmune

April 11, 2023

·

3 min read

Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q4 ’22

April 11, 2023

·

1 min read

Defence Breakthrough: Successfully Engineered Accum(TM)-mRNA Vaccine Creating a New Vaccine Platform. The in vivo Accum(TM)-mRNA Cancer Vaccine Program Begins

April 11, 2023

·

4 min read

Business

NervGen Pharma Appoints Michael Kelly as President & Chief Executive Officer

April 10, 2023

·

8 min read

PsyBio Announces Panel Participation on NextGen Psychedelics at Benzinga Cannabis Capital Conference

April 6, 2023

·

6 min read

American Aires Inc. Announces Filing of 2022 Financial Statements and MD&A

April 6, 2023

·

5 min read

Policy

Nova Mentis Provides Corporate Update and 2023 Outlook

April 5, 2023

·

5 min read

Moss Introduces Cognitive Health Test

April 5, 2023

·

5 min read

Global Hemp Group Announces Final Payment Made Relating to the Exclusive Licensing of Apollon Formularies PLC Patents and Intellectual Property

April 4, 2023

·

4 min read

Drug Development

Skye Bioscience Receives Positive Safety Review of Third Cohort in Phase 1 Study of SBI-100 Ophthalmic Emulsion

April 4, 2023

·

3 min read

15 Toronto St., Suite 601 Toronto ON M5C 2E3 US

Tel: 416-806-1750